Roivant Sciences ROIV
NASDAQ ROIV
$36.49 -0.96 (-2.56%)
At close: Oct 23, 2026 · 4:00 PM EDT

Roivant Sciences (ROIV) Cost of Revenue (2020 - 2026)

Updated

Roivant Sciences (ROIV) reported Cost of Revenue of $284,000 for fiscal Q1 2027 (quarter ended Jun 30, 2026), up 84.4% from $154,000 a year earlier but down 11.3% from the prior quarter.

Analysis

Roivant Sciences (ROIV) Cost of Revenue (2020 - 2026) Analysis & Trends

Over the twelve months ended Jun 30, 2026, Roivant Sciences' Cost of Revenue came in at $1.42 million, up 66.1% year-over-year; for FY2026 (ended Mar 31, 2026), it came in at $1.29 million, up 41.1% from FY2025.

  • Cost of Revenue has a five-year compound annual growth rate of -9.0% (FY2021 to FY2026).
  • By fiscal year, Cost of Revenue came in at $911,000 in FY2025 (-43.0%), $1.6 million in FY2024 (-47.3%), $3.03 million in FY2023 (-66.2%) and $8.97 million in FY2022 (+335.9%).
  • Five-year quarterly Cost of Revenue spans a low of -$5.92 million in fiscal Q4 2023 and a high of $6.38 million in fiscal Q2 2022.
  • Year over year, Cost of Revenue has now increased in each of the last three quarters, with growth averaging 33.9% over the last eight quarters.
  • The high point for year-over-year Cost of Revenue in five years was fiscal Q2 2022 (growth of 792.4%); the low point was fiscal Q1 2025 (a decline of 94.9%).
  • Per Business Quant data, the three fiscal quarters before Q1 2027 came in at $320,000 (Q4 2026), $700,000 (Q3 2026) and $111,000 (Q2 2026).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cost of Rev (Qtr)
1 Eli Lilly 1,199.50 Bn 1,168.08 Bn 19.71 Bn 3.27 Bn
2 Johnson & Johnson 635.17 Bn 555.03 Bn 17.30 Bn 8.10 Bn
3 AbbVie 504.69 Bn 477.85 Bn 12.70 Bn 4.29 Bn
4 Merck 358.43 Bn 312.86 Bn 12.21 Bn 4.40 Bn
5 Novartis Ag 288.36 Bn 252.75 Bn 11.24 Bn 3.71 Bn
6 Astrazeneca 265.78 Bn 239.54 Bn 12.86 Bn 2.52 Bn
7 Amgen 237.46 Bn 192.86 Bn 7.24 Bn 2.81 Bn
8 Gilead Sciences 193.65 Bn 167.76 Bn 6.22 Bn 1.58 Bn
9 Pfizer 171.05 Bn 118.00 Bn 10.94 Bn 4.09 Bn
10 Roivant Sciences 26.37 Bn 10.01 Bn 1.16 Mn 284,000.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 284,000.00
Mar 31, 2026 320,000.00
Dec 31, 2025 700,000.00
Sep 30, 2025 111,000.00
Jun 30, 2025 154,000.00
Mar 31, 2025 205,000.00
Dec 31, 2024 259,000.00
Sep 30, 2024 234,000.00
Jun 30, 2024 213,000.00
Mar 31, 2024 196,000.00
Dec 31, 2023 197,000.00
Sep 30, 2023 223,000.00
Jun 30, 2023 4.21 Mn
Mar 31, 2023 -5.92 Mn
Dec 31, 2022 3.59 Mn
Sep 30, 2022 3.64 Mn
Jun 30, 2022 1.73 Mn
Mar 31, 2022 459,000.00
Dec 31, 2021 1.38 Mn
Sep 30, 2021 6.38 Mn
API Access

Roivant Sciences Cost of Revenue API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=cost-of-revenue&ticker=ROIV&period=max&api_key=YOUR_API_KEY